Patents by Inventor Robert McKay

Robert McKay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10569792
    Abstract: A system and method for examining a route and/or vehicle system obtain a route parameter and/or a vehicle parameter from discrete examinations of the route and/or the vehicle system. The route parameter is indicative of a health of the route over which the vehicle system travels. The vehicle parameter is indicative of a health of the vehicle system. The discrete examinations of the route and/or the vehicle system are separated from each other by location and/or time. The route parameter and/or the vehicle parameter are examined to determine whether the route and/or the vehicle system is damaged and, responsive to determining that the route and/or the vehicle is damaged, the route and/or the vehicle system are continually monitored, such as by examination equipment onboard the vehicle system.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: February 25, 2020
    Assignee: General Electric Company
    Inventors: Sameh Fahmy, Jared Klineman Cooper, Ajith Kuttannair Kumar, Joseph Forrest Noffsinger, Wolfgang Daum, Glenn Robert Shaffer, Paul Kenneth Houpt, David Lowell McKay
  • Patent number: 10487629
    Abstract: A downhole control method for use in a wellbore that includes deploying a stand-alone power source and a stand-alone hydraulic reservoir downhole; powering a downhole controller using the stand-alone power source; measuring a downhole fluid parameter; and actuating an inflow control device, using the stand-alone hydraulic reservoir and the downhole controller, based on the measured downhole fluid parameter. In one aspect, the stand-alone power source is selected from the group consisting of a battery and a downhole power generator. In another aspect, the stand-alone hydraulic reservoir, the downhole controller, the stand-alone power source, and the inflow control device comprise a remotely-powered, open-hole completion system.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: November 26, 2019
    Assignee: HALLIBURTON ENERGY SERVICES, INC.
    Inventors: Savio Saldanha, Matthew Scogin, Timothy R. Tips, Colin McKay, Michael R. Konopczynski, James Flygare, Robert Smith
  • Publication number: 20190340868
    Abstract: A method of positioning a monitor frame using a counter-balanced hinging mechanism coupled to the monitor frame and seating a display monitor within the monitor frame includes rotating the monitor frame into an approximately horizontal orientation using the counter-balanced hinging mechanism, where the counter-balanced hinging mechanism may include at least one arm linkage assembly, and at least one bias member coupled to the at least one arm linkage assembly. The method also includes aligning an outer edge of the display monitor with an inner surface of the monitor frame, translating the display monitor to a seated position within the monitor frame, and rotating the monitor frame into an approximately vertical orientation using the counter-balanced hinging mechanism.
    Type: Application
    Filed: July 17, 2019
    Publication date: November 7, 2019
    Inventors: Rena Schoonmaker, Bruce Urban, Matthew McKay, Noel Voloh, Robert Wand, Gary Strahinic
  • Publication number: 20190340867
    Abstract: A system for supporting a plurality of display monitors includes a support stanchion having a first anchor end, a second coupling end, and a stanchion body extending therebetween. The system also includes at least one counter-balanced hinging mechanism coupled to the second coupling end of the support stanchion and at least one monitor frame. The counter-balanced hinging mechanism includes at least one arm linkage assembly configured to permit the at least one monitor frame to pivot with respect to the support stanchion, and at least one bias member coupled to the at least one arm linkage assembly. The at least one bias member is configured to apply a variable amount of force to maintain the at least one monitor frame stationary in any of a plurality of intermediate positions between an approximately vertical operational position and an approximately horizontal maintenance position.
    Type: Application
    Filed: July 17, 2019
    Publication date: November 7, 2019
    Inventors: Rena Schoonmaker, Bruce Urban, Matthew McKay, Noel Voloh, Robert Wand, Gary Strahinic
  • Patent number: 10445973
    Abstract: A method and system for an overhead display assembly for an electronic machine are provided. The overhead display assembly includes a display monitor supported in a monitor frame translatable between an operational position and a maintenance and installation position angularly displaced from the operational position by a predetermined angle. The overhead display assembly also includes a support stanchion including a first anchor end, a second coupling end, and a stanchion body extending therebetween, the first anchor end configured to couple to a supporting structure. The overhead display assembly further includes a counter-balanced hinging mechanism coupled to and between the second coupling end and the monitor frame.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: October 15, 2019
    Assignee: ARISTOCRAT TECHNOLOGIES AUSTRALIA PTY LIMITED
    Inventors: Rena Schoonmaker, Bruce Urban, Matthew McKay, Noel Voloh, Robert Wand, Gary Strahinic
  • Publication number: 20190255133
    Abstract: The present invention provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analogue or derivative thereof and (ii) a penetration enhancer, and optionally including tannic acid, or an analogue or derivative thereof. The present invention also provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analogue or derivative thereof, and (ii) tannic acid, or an analogue or derivative thereof, optionally including a penetration enhancer. Also provided are kits and methods of prophylactic or therapeutic treatment of inflammatory and/or degenerative conditions using the combination of active ingredients as herein described.
    Type: Application
    Filed: April 29, 2019
    Publication date: August 22, 2019
    Applicant: Arthritis Relief Plus Ltd.
    Inventors: Larry MCKAY, Kanu PATEL, Robert John CAPON
  • Patent number: 10322155
    Abstract: The present invention provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analog or derivative thereof and (ii) a penetration enhancer, and optionally including tannic acid, or an analog or derivative thereof. The present invention also provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analog or derivative thereof, and (ii) tannic acid, or an analog or derivative thereof, optionally including a penetration enhancer. Also provided are kits and methods of prophylactic or therapeutic treatment of inflammatory and/or degenerative conditions using the combination of active ingredients as herein described.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: June 18, 2019
    Assignee: ARTHRITIS RELIEF PLUS LTD.
    Inventors: Larry McKay, Kanu Patel, Robert John Capon, Kay McKay
  • Publication number: 20190176862
    Abstract: System includes a controller configured to obtain one or more of a route parameter or a vehicle parameter from discrete examinations of one or more of a route or a vehicle system. The route parameter is indicative of a health of the route over which the vehicle system travels. The vehicle parameter is indicative of a health of the vehicle system. The discrete examinations of the one or more of the route or the vehicle system separated from each other by one or more of location or time. The controller is configured to examine the one or more of the route parameter or the vehicle parameter to determine whether the one or more of the route or the vehicle system is damaged. The system also includes examination equipment configured to continually monitor the one or more of the route or the vehicle system responsive to determining that the one or more of the route or the vehicle is damaged.
    Type: Application
    Filed: February 14, 2019
    Publication date: June 13, 2019
    Inventors: Ajith Kuttannair Kumar, Wolfgang Daum, Martin Paget, Daniel Rush, Brad Thomas Costa, Seneca Snyder, Jerry Duncan, Mark Bradshaw Kraeling, Michael Scott Miner, Shannon Joseph Clouse, Anwarul Azam, Matthew Lawrence Blair, Nidhi Naithani, Dattaraj Jagdish Rao, Anju Bind, Sreyashi Dey Chaki, Scott Daniel Nelson, Nikhil Uday Naphade, Wing Yeung Chung, Daniel Malachi Ballesty, Glenn Robert Shaffer, Jeffrey James Kisak, Dale Martin DiDomenico, Suresh Govindappa, Manibabu Pippalla, Sethu Madhavan, Arunachala Karthik Sridharan, Prabhu Marimuthu, Jared Klineman Cooper, Joseph Forrest Noffsinger, Paul Kenneth Houpt, David Lowell McKay
  • Publication number: 20170228726
    Abstract: A system may transmit a time-based token to the merchant device. The system may receive a second merchant session key, a customer session key, a customer ID, a customer device certificate, and a second transaction amount from a customer device. The system may further match the first merchant session key to the second merchant session key, and transmit the time-based token to the customer device in response to the first merchant session key matching the second merchant session key.
    Type: Application
    Filed: February 4, 2016
    Publication date: August 10, 2017
    Applicant: AMERICAN EXPRESS TRAVEL RELATED SERVICES COMPANY, INC.
    Inventors: Billy Bohanan, Brady Cullimore, Justin Flaishans, Dinesh Gudibandi, Sean Maize, Robert Mckay, ShahanasSalam NaduvilePurayil, Rakesh Pattanayak, Dan Sorensen, Andrew Sosnicki
  • Patent number: 9617540
    Abstract: The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: April 11, 2017
    Assignee: Ionis Pharmaceuticals, Inc.
    Inventors: Sanjay Bhanot, Richard S. Geary, Robert McKay, Brett P. Monia, Punit P. Seth, Andrew M. Siwkowski, Eric E. Swayze, Edward Wancewicz
  • Patent number: 9447591
    Abstract: A tool for finishing an outside corner comprises a handle and a V-shaped blade coupled to the handle. The V-shaped blade has a pair of planar blade surfaces which each extend from a vertex thereof. A retaining mechanism releasably retains a sponge against the surfaces of the V-shaped blade.
    Type: Grant
    Filed: September 15, 2014
    Date of Patent: September 20, 2016
    Inventor: Robert McKay
  • Publication number: 20150344879
    Abstract: The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing.
    Type: Application
    Filed: April 28, 2015
    Publication date: December 3, 2015
    Applicant: ISIS PHARMACEUTICALS, INC.
    Inventors: Sanjay Bhanot, Richard S. Geary, Robert McKay, Brett P. Monia, Punit P. Seth, Andrew M. Siwkowski, Eric E. Swayze, Edward Wancewicz
  • Patent number: 9071974
    Abstract: Methods, systems, and software for mediating SMS messages, and especially type 0 SMS messages, in a wireless mobile communications device configured to send and receive data using a GSM protocol and including a subscriber identity module (“SIM”) including electronic hardware and computer software executed by the hardware such that the SIM is configured to send, receive, and process messages using a Short Message System (“SMS”) between the wireless mobile communications device and a communications network. One aspect includes a method for mediating SMS messages comprising: configuring electronic hardware on the wireless mobile communications device to implement a firewall on the wireless mobile communications device, the firewall configured to identify and optionally mediate infrastructure SMS messages.
    Type: Grant
    Filed: June 28, 2009
    Date of Patent: June 30, 2015
    Assignee: Oceans Edge, Inc.
    Inventors: Robert McKay, Sam Emara, Steve Hildner, Thomas Shanley, Wesley Driver, Jay Lukin, Terry Bahr, Tim Berzins, Mihaela Mihaylova, Nathan Klonoski
  • Publication number: 20150167323
    Abstract: A tool for finishing an outside corner comprises a handle and a V-shaped blade coupled to the handle. The V-shaped blade has a pair of planar blade surfaces which each extend from a vertex thereof. A retaining mechanism releasably retains a sponge against the planar blade surfaces V-shaped blade.
    Type: Application
    Filed: September 15, 2014
    Publication date: June 18, 2015
    Inventor: Robert McKay
  • Patent number: 9045754
    Abstract: The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: June 2, 2015
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Sanjay Bhanot, Richard S. Geary, Robert McKay, Brett P. Monia, Punit P. Seth, Andrew M. Siwkowski, Eric E. Swayze, Edward Wancewicz
  • Patent number: 8969316
    Abstract: The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: March 3, 2015
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Sanjay Bhanot, Richard S. Geary, Robert McKay, Brett P. Monia, Punit P. Seth, Andrew M. Siwkowski, Eric E. Swayze, Edward Wancewicz
  • Publication number: 20150057329
    Abstract: The present disclosure describes short antisense compounds, including such compounds comprising chemically-modified high-affinity monomers 8-16 monomers in length. Certain such short antisense compound are useful for the reduction of target nucleic acids and/or proteins in cells, tissues, and animals with increased potency and improved therapeutic index. Thus, provided herein are short antisense compounds comprising high-affinity nucleotide modifications useful for reducing a target RNA in vivo. Such short antisense compounds are effective at lower doses than previously described antisense compounds, allowing for a reduction in toxicity and cost of treatment. In addition, the described short antisense compounds have greater potential for oral dosing.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 26, 2015
    Applicant: Isis Pharmaceuticals, Inc.
    Inventors: Sanjay BHANOT, Richard S. Geary, Robert McKay, Brett P. Monia, Punit P. Seth, Andrew M. Siwkowski, Eric E. Swayze, Edward Wancewicz
  • Publication number: 20140357856
    Abstract: The present invention relates to novel chimeric oligomeric compounds having a plurality of alternating regions having either RNA like having northern or 3?-endo conformational geometry (3?-endo regions) or DNA like having southern or C2?-endo/O4?-endo conformational geometry. The oligomeric compounds of the present invention have shown reduction in mRNA levels in multiple in vitro and in vivo assay systems and are useful, for example, for investigative and therapeutic purposes.
    Type: Application
    Filed: June 13, 2014
    Publication date: December 4, 2014
    Applicant: ISIS PHARMACEUTICALS, INC.
    Inventors: Brett P. Monia, Madeline M. Butler, Robert McKay, Brenda F. Baker
  • Patent number: 8853178
    Abstract: Compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: October 7, 2014
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Sanjay Bhanot, Lex M. Cowsert, Jacqueline R. Wyatt, Brett P. Monia, Madelline M. Butler, Robert McKay, Susan M. Freier, Kenneth W. Dobie
  • Patent number: D864033
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: October 22, 2019
    Assignee: Thor Tech, Inc.
    Inventors: James Jack Owen Devine, Dale Beever, Raymond McKay Featherstone, Bryan M. Fox, Dana Kim Gehman, Bradley J. Mitchell, Robert Owen Sanford, Bryan Thompson